Skip to main content
[Preprint]. 2024 Mar 9:2024.03.08.584176. [Version 1] doi: 10.1101/2024.03.08.584176

Table 1.

Description and demographics for participants selected for this study.

Study Group Sex Age (years) Baseline HAI Titer # with Day 0 and Day 30 # with Day 182 Vaccine received in 2020–2021 Vaccine received in 2021–2022

1x Vax Male 24–44 5 8 6 Placebo FluBlok
Female 20–29 5 7 4 Placebo FluBlok
2x Vax Male 23–45 5 8 7 FluBlok FluBlok
Female 25–43 5 7 3 FluBlok FluBlok